Seroba Lifesciences is a European life sciences venture capital firm focused on value creation through backing innovations in biotech and medtech.

Seroba Lifesciences

Domain Not Resolving

Microsoft Exchange Online

DMARC

IPv6

Office 365 Mail

Mailgun

TOPSEC

Niall Olden

Andrew Duignan

Maud Lazare

Partner, Head of Investor Relations

Alan O'Connell

Partner

Peter Sandys

Chairman

Jennifer McMahon

Principal

Bruno Montanari

Seamus O’Hara

Director

Jennifer McKeever

Fusion Pharmaceuticals is a clinical-stage oncology company focused on developing radiopharmaceuticals.

Endotronix is a developer of hemodynamic monitoring technologies to help detect worsening heart failure earlier than ever before.

INNOVO by Atlantic Therapeutics is a medical technology firm that develops pelvic floor muscle strengthening and nerve stimulation products.

Veryan Holdings is a medical device company developing three dimensional vascular stents for peripheral vascular disease.

PQ Bypass is a medtech company advancing the treatment of long-segment peripheral artery disease.

Prexton Therapeutics has the mission to develop innovative drugs to improve the quality of life.

Biosensia is a diagnostics company developing point-of-care platforms used for a variety of common biological sample types.

Covagen develops protein-based therapeutics for the treatment of inflammatory diseases and cancer.

Novate Medical is a development stage medical device company in Galway, Ireland.

Apica Cardiovascular is a developer of cardiovascular devices.

Early Stage Venture Investors with Investments in United Kingdom

Investors Active in United States (Top 10K)

Early Stage Venture Investors with Investments in Great Lakes

Early Stage Venture Investors with Investments in Paris, Ile-de-France

Seroba is a life sciences venture capital firm, focused on investing in breakthrough healthcare technologies that promise to improve lives and make a difference worldwide.

Headquartered in Ireland, the firm works with some of the world’s best entrepreneurs developing innovative medical devices, diagnostics, and therapeutic drugs. It funds new healthcare opportunities through key value-adding stages, assisting its invested companies from inception through development and clinical evaluation, the generation of intellectual property, regulatory approvals and market launch, and partnering with leading pharmaceutical or medtech companies.

The Seroba team combines in-depth scientific and medical knowledge with broad regulatory and commercial expertise. They are known for patience, understanding, commitment and passion, well-demonstrated by the caliber of entrepreneurs they back, and an overriding focus on delivering improvements to people's lives and value to their stakeholders.

Seroba Life Sciences Fund III

Seroba Life Sciences Fund II

Dublin

Ireland

Europe

Seroba Life Sciences

Seroba and Kurma Partners Announce Complementary Series B Funding for Vico Therapeutics totaling €65.8 million ($70.7 million)

United States

North America

Israel

Asia

Germany

Spain

India

news_impact_assignment_basic

key_people

merger_acquisitions

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	Oct 2, 2024 1:29 PM	63c2b283
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general	Oct 9, 2024 11:59 PM	1dfcfd49
company summary	general
signals	general	Oct 2, 2024 1:29 PM	9999a1ba
crunchbase trigger	general	Nov 18, 2024 2:12 PM	5831a087
crunchbase profile	general	Nov 19, 2024 10:37 AM	9c1f7b95
li profile	general
translate crunchbase fundingrounds	general	Nov 19, 2024 10:56 AM	c2b1f51d
peers	general	Oct 2, 2024 1:29 PM	f3fa645f
news basic	general	Oct 2, 2024 1:29 PM	630aa95a
bundesanzeiger	filings
financials download nd	financials
private financials	financials

COM:SEROBA-LIFESCIENCES

Seroba Lifesciences